Immunai
Developer of an immune system technology designed to provide treatments for oncology and auto-immune disorders.
Discovery Tools (Healthcare)
📍 New York, NY
Founded 2018
Current Valuation
$960M
as of 2021-Q4
PRIVATE
Developer of an immune system technology designed to provide treatments for oncology and auto-immune disorders.
Company Profile
Last Round
Series C — $204M (Dec 2021)
Fundraising Status
Series C · $204M · 4y 6mo ago
privateTotal raised $584M
Latest Funding Round
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Series C | $204M | Dec 2021 | — | $960M |
Machine LearningArtificial IntelligenceBiotechnologyTherapeuticsAnalytics
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2021-Q4. Refreshed quarterly.